. 2019 Sep 30;13:1641–1653. doi: 10.2147/PPA.S219920

Table 1.

Drug, Daily Dosage, Price, Classification In China’s National Basic Medical Insurance List And Recommended In The Standardized Treatment Regimen

Group	Description	Drug (Abbrev.)	Daily Dosage (mg) By Patient Weight			Range Of Monthly Cost (CNY)	Included In National Basic Medical Insurance List			Recommended In Standardized Treatment Regimen
Group	Description	Drug (Abbrev.)	<50 kg	≥50 kg	Maximum	Range Of Monthly Cost (CNY)	Yes		No^c	Recommended In Standardized Treatment Regimen
Most preferred^a	Preferred^b
1	First-line oral anti-TB drugs	Pyrazinamide (Z)	1500	1750	2000	58–96	√			√
Ethambutol (E)	750	1000	1500	21–34	√			√
2	Injectable anti-TB drugs	Amikacin (Am)	400	400–600	800	72–108	√			√
2	Injectable anti-TB drugs	Capreomycin (Cm)	750	750	750	712		√		√
Kanamycin (Km)	500	750	1000	1500			√	√
3	Fluoroquinolones (FQs)	Ofloxacin (Ofx)	400	600	800	110–165	√
3	Fluoroquinolones (FQs)	Levofloxacin (Lfx)	400	500	600	60–110	√			√
Moxifloxacin (Mfx)	400	400	400	698		√		√
4	Oral bacteriostatic second-line anti-TB drugs	Prothionamide (Pto)	600	600–800	800	40–53		√		√
4	Oral bacteriostatic second-line anti-TB drugs	p-aminosalicylic acid (PAS)	8000	10,000	12,000	600–900	√			√
Cycloserine (Cs)	500	750	1000	1620–1920		√		√
5	Anti-TB drugs with limited data on efficacy and/or long-term safety in the treatment of drug-resistant TB	Amoxicillin/Clavulanate (Amx/Clv)	1125	1,500	1500	1260–1680	√
		Clarithromycin (Clr)	500	750	1000	126–252		√
		Linezolid (Lzd)	300	300–600	600	9600–19,200		√
Clofazimine (Cfz)	100	100	100	1248		√

Notes: ^aMost preferred: totally reimbursed by insurance ;¹³^,¹⁵ bPreferred: partially reimbursed by insurance system;¹³^,¹⁵ cNo: paid out-of-pocket.

Abbreviations: MDR-TB, multidrug-resistant tuberculosis; CNY, Chinese yuan.